Diabetes mellitus (DM) is a heterogeneous metabolic disorder characterized by the presence of hyperglycemia due to impairment of insulin secretion, defective insulin action, or both, which requires continuous medical care with multifactorial risk-reduction strategies beyond glycemic control. This evidence concerns the gene INS and metabolic disease.